Tango Therapeutics

Tango Therapeutics is a company that states it is leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors, using an approach that starts and ends with patients to expand the reach of genetically targeted therapies. Its official website lists a Boston, Massachusetts address and telephone contact, and features news items including inducement grants under Nasdaq Listing Rule 5635(c)(4), participation in the 2026 Cantor Global Healthcare Conference, second quarter 2026 financial results, and an executive chair transition.

Tango Therapeutics describes its approach as leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors, using an approach that starts and ends with patients to expand the reach of genetically targeted therapies. Its official website lists a Boston, Massachusetts address and telephone contact, and features news items including inducement grants under Nasdaq Listing Rule 5635(c)(4), participation in the 2026 Cantor Global Healthcare Conference, second quarter 2026 financial results, and an executive chair transition.

Leveraging synthetic lethality to develop medicines that take direct aim at specific tumors, expanding the reach of genetically targeted therapies.

1. 1Tango Therapeuticstangotx.com
2. 2Tango Therapeutics (United States)wikidata.org
3. 3Gilead Expands Collaboration With Tango for Cancer Therapiesfinance.yahoo.com